Submitted by Exponential Times on Thu, 2014-05-08 06:19
May 06, 2014
The Baker Institute brings together leaders from academia, government, insurance and industry to discuss how information technology can be used effectively to improve health care and how to address the policy and regulatory impediments to progress.
Submitted by Exponential Times on Sun, 2014-03-16 22:19
Myshkin is co-founder and CEO of Biosense Technologies, a medical device venture designing and building innovative, disruptive healthcare technologies focusing on point of care non-invasive diagnostics. He is also a TED Senior Fellow 2013, a TED Fellow 2012, an Unreasonable Fellow 2011, and the recipient of the Anjani Mashelkar Award for Inclusive Innovation 2012. His work featured in major media publications such as BBC, CNN, Guardian, WIRED, TechCrunch, Economic Times. He is a co-author of the book "The Unreasonable Fellows".
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)
Exploring and driving the future of health & medicine through fast moving, convergent game changing technologies.
Exponential Medicine educates, informs and prepares physicians, innovators, inventors, investors and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare, and to understand how many rapidly developing and converging fields affect the future of wellness, prevention, clinical practice and the biomedical industry.
Understand how healthcare is being re-invented and disrupted through rapidly developing technologies such as low cost genomic sequencing, artificial intelligence, telemedicine, robotics, 24/7 body wearable monitors, smart pills, stem cells, synthetic biology, gene therapy, mobile phone apps and crowd-sourced health data affect the future of healthcare and medicine?
Exponential Medicine at Singularity University is a one-of-a-kind program that focuses on disruptive, game-changing exponential technologies that will revolutionize the practice of medicine and radically transform healthcare and the biomedical industry in the decade ahead.
Submitted by Exponential Times on Fri, 2014-01-17 11:41
Google have jumped on the wearable electronics band wagon with a prototype contact lens which could be a lifeline to millions of diabetes sufferers worldwide. The lens measures the glucose levels in the tears of the wearer using a minute sensor, which it analyses to assess their blood sugar level.
Submitted by Exponential Times on Thu, 2013-11-21 23:37
peaker/Performer: Jana Katz-Bell, Assistant Dean, Interprofessional Programs, UC Davis School of Medicine and Betty Irene Moore School of Nursing
Sponsor: CITRIS (Ctr for Info Technology Research in the Interest of Society)
Information and telecommunications technology have evolved drastically over the past 2 decades and transformed many industries. Healthcare has experienced important changes but continues to lag. What have we learned from our experiences that inform us as we explore the implementation of various technologies designed to advance quality and access? What is the status of telehealth/eHealth/Connected Health in California, especially as it relates to vulnerable populations? This talk will explore these themes and the importance for on-going, multi-disciplinary engagement. Jana Katz-Bell will approach this topic not as a healthcare provider nor an engineer -- but as a person who has been involved in implementation of many telehealth applications over the past decade and from a policy and sustainability perspective.
Submitted by Exponential Times on Mon, 2013-11-18 06:30
Sam is the Founder and CEO of Adamant Technologies, which provides users of their devices with real-time, non-invasively measured, actionable data about the state of their body. Adamant hopes to empower users to track and manage chronic diseases and improve quality of life for people afflicted with disorders including obesity, asthma, COPD and Diabetes all through measurements taken from their breath. Sam founded Adamant to bridge the gap that exists today between the next generation of personal mobile medical devices and applications and the devices of today, empowering users to take control of their health and wellness in a way not previously possible. A physicist and nanotechnologist by training, Sam has spent the last 10 years applying novel technologies to solve problems that face the general public.
Submitted by Exponential Times on Mon, 2013-11-18 06:16
Chad Priesttalks about his perspective as a healthcare provider in multiple professions: as a military nurse, a healthcare lawyer, university faculty member and most recently as the CEO of a non-profit crisis management organization. Through these experiences, he has come to believe that in order to create health you have to mix it up. Mix up the professions and the interactions. Priest is a dad, a husband, a nurse, an attorney, an Air Force veteran and the CEO of the MESH Coalition, an emergency management organization. But if you ask him, he'll just tell you he's a healthcare provider on a mission to change the way we think about healthcare and who provides it. To create health, we must mix it up: crossing professions and cross-pollinating solutions that lead to breakthrough thinking.
The Consumer Genetics Conference (CGC) is a one-of-a-kind event that draws together a dynamic community of scientists, clinicians, technology innovators, and patients to discuss the burning issues around the analysis and delivery of genomics results directly to patients and consumers. Over three days, attendees will hear about disruptive diagnostic technologies, cognitive barriers to patients (and medical professionals), ethical/regulatory/privacy issues, the thorny issue of reimbursement, and the challenges of building relationships to realize the potential of personal genomics and individualized medicine. CGC provides an opportunity for all stakeholders to come together at one venue, share viewpoints and engage in an honest dialogue, and together learn how to move the elephant of change.
Strata Rx focuses on using big data to drive innovations in analytics for healthcare—including advances in personalized and predictive medicine; significant cost savings; and research that points to entirely new products and markets.
Strata Rx is a unique forum bringing together the diverse communities driving innovations in big data analytics for healthcare. Healthcare leaders in areas such as drug development and medical devices can meet with payers, providers, mobile health pioneers, health IT practitioners, and patients, as well as developers, statisticians, analysts, and innovators.
Strata Rx is also a rare East-meets-West opportunity for the medical establishment to mingle with the Silicon Valley technorati to learn about the transformation of healthcare through big data and how to position themselves to benefit from these trends.
The explosion of health data and data science techniques, coupled with the challenge of improving the healthcare system, from both a cost and quality standpoint, has led to renewed interest in health data analytics. However, effective solutions must be communicated in ways the invested parties can intuitively understand and buy into. Health Economists, Policy Analysts, Bio-statisticians and the like, serve this role in Pharma, Medical Devices, and BioTech, and have been using data analysis and modeling to understand the application of their products to problems of cost and care. They have a practical understanding of the issues facing companies looking to build next generation products.